There are conflicting reports as to whether malignant peripheral nerve sheath tumor
(MPNST) patients with neurofibromatosis type 1 (NF1) have worse prognosis than non-NF1 …

MPNST is the sixth most common type of soft-tissue sarcoma, accounting for approximately
5% to 10% of cases. 1–3 Although its exact cellular origins remain unclear, most MPNSTs …

Inside the Sixth Edition of this now-classic reference, you will discover encyclopedic
coverage of topics ranging from basic science to sophisticated computer-based radiation …

BACKGROUND Histologic grade is said to be the most important prognostic factor in adult
soft tissue sarcomas (STS), but most grading systems have been tested in the overall …

Background Malignant peripheral nerve sheath tumors (MPNST) are a rare form of soft
tissue sarcoma with few studies reporting on patient outcomes and prognostic variables …

BACKGROUND. The authors explored the prognostic factors and clinical outcomes of
patients who had malignant peripheral nerve sheath tumors (MPNST) with and without …

Objective: Improved staging systems for malignant peripheral nerve sheath tumor (MPNST)
prognostication and management are needed. Consequently, we sought to identify clinical …

BACKGROUND The objectives of this study were to evaluate the risk of local recurrence and
survival after soft tissue sarcoma (STS) resection with positive margins and to evaluate the …

Background: The role of chemotherapy in advanced malignant peripheral nerve sheath
tumor (MPNST) is unclear. Patients and methods: Chemotherapy-naive soft tissue sarcomas …

The two main peripheral nerve sheath tumors found in patients with neurofibromatosis, type
1 (NF1), are neurofibroma, a benign tumor, and malignant peripheral nerve sheath tumor …